Project Grant R01HL173600

Award Date 9/17/24
Completion Date 6/30/28
Dollars Obligated $797K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award, valued at $154,861 and provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), aims to advance the integration of social and medical care to promote health equity among children with asthma. The key products and services to be delivered under this grant include: Developing a population-based machine learning model to predict risk of asthma-related hospitalization among children in Washington, D.C. using social...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, provides $180,174 to The Children's Hospital of Philadelphia (CHOP) to develop a framework for designing the next generation of pediatric acute respiratory distress syndrome (ARDS) clinical trials. The key objectives of this 5-year project are to: 1) compare heterogeneity of treatment effect analysis methodologies in a pediatric ARDS...
The Project Grant award K23HL163253, totaling $178,783, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will support Dr. Pappalardo's research to understand barriers and develop targeted implementation strategies for school-based stock inhaler programs, with the goal of improving asthma management and reducing health disparities. The grant will fund a community-engaged, implementation science...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,401,548 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Arizona. The grant, titled "Breathing Easier in Schools: Enhancing Adoption, Fidelity, and Effectiveness of the SAFE School Program through Innovation Implementation Strategies," aims to explore three implementation strategies to support the adoption, maintenance, and effectiveness of a school-based stock...
This Project Grant award of $274,392, provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), supports research on the social determinants of health (SDOH) and their impact on asthma-related morbidity among Black and Latinx adults with moderate-severe asthma. The key objectives are to: 1) determine if Black and Latinx adults have unique SDOH exposomes that distinctly associate with worse asthma outcomes, 2) assess if African American Black adults...
This $673,581 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to assess disparities in asthma care between Latino and non-Hispanic white adults, and identify the social determinants of health that may underlie these disparities. The grantee, Ochin, Inc., a nonprofit health IT collaborative based in Portland, Oregon, will leverage a large national dataset of electronic health records from...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $834,840 to Brigham & Women's Hospital to conduct research on emulating hypothetical target trials to establish the comparative effectiveness of biologics in treating severe asthma. The research aims to optimize the use of expensive monoclonal antibody biologics for patients with severe asthma who are eligible for multiple...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $156,899 to Indiana University Indianapolis to conduct research on identifying distinct clinical phenotypes in children presenting with status asthmaticus and evaluating the effects of adjunctive asthma treatments across these phenotypes. The 5-year project aims to: (1) identify clinical phenotypes in pediatric status asthmaticus, (2) validate these...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $393,180 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Texas Woman's University (TWU) to develop and validate a self-management questionnaire for adolescents with asthma. The 3-year project aims to create a reliable and valid instrument to assess asthma self-management behaviors and cognitive autonomy in adolescents aged 12-21. The research will involve qualitative and quantitative approaches,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $164,453 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the Arkansas Children's Research Institute (ACRI) on September 15, 2024. The grant will fund a 4-year research project titled "Multifactorial Asthma Determinants in Underresourced Pediatric Populations." The project aims to investigate disparities in pediatric asthma prevalence and morbidity, particularly among racial/ethnic minority and rural,...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $797,130 to The Children's Hospital of Philadelphia (CHOP) from September 2024 to June 2028. The project aims to implement and evaluate the real-world effectiveness of "single maintenance and reliever therapy" (SMART) for managing moderate-to-severe childhood asthma in a predominantly Black pediatric population. The study uses a cluster-randomized design to compare usual care to two successive implementation strategies: (1) electronic health record-based clinical decision support plus provider/patient education, and (2) the addition of population health management, including longitudinal caregiver/patient education and support. The project's goals are to increase SMART adoption, evaluate its real-world effectiveness in reducing severe asthma exacerbations, and assess the mechanisms of successful SMART implementation and effectiveness.

Generated 7/1/25, 3:08 AM